Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. - Wikidata - awgldk - TriplyDB

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

http://www.wikidata.org/entity/Q34366802

about

Is it safe to use smoking cessation therapeutics during pregnancy?Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers Extracts from presumed "reduced harm" cigarettes induce equivalent or greater toxicity in antigen-presenting cells.Feeding Two Birds with One Scone: The Case of Varenicline.Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.

P2860

Q34444221-2EFAA2E9-20F2-4685-B8C7-C229E6DC6E8D Q34870758-C29C28F5-3993-4C2E-95D4-E4882FD23720 Q35892818-F455D760-FCBF-47B1-9BD4-FB707C74736B Q35910691-ED111DE3-FAD3-4EC6-ACF5-28CFF8C79D9B Q35940846-9AFC6D66-C857-4EA2-AD04-9E265A1981C1 Q38636469-3BBAC828-7B73-4A36-B5B1-3F57BC4C987B Q51462591-B2C31546-1077-44A2-B004-679EC8C90AF9

P2860

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

http://www.wikidata.org/entity/Q34366802

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@ast

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@en

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@nl

type

label

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@ast

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@en

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@nl

prefLabel

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@ast

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@en

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@nl

P1433

Q34366802-E568249D-B6F1-4FED-9B08-55B8D8FE5F30

P1476

Q34366802-A2CD2231-FE3A-46B4-881D-DF7D35229F14

P2093

Q34366802-7DA47F61-FB4D-415D-946B-0E6447F6F224

Q34366802-C1CB6C21-A2A7-4349-ACA1-420D9F86856C

P2860

Q34366802-000E3A25-08D9-4E89-A762-7BCBD30F97F2

Q34366802-02CF3134-1432-4339-9181-EF83E407BAF3

Q34366802-068EE7FC-9A1A-4286-8F20-29B521B9630F

Q34366802-09469CF1-D9F1-42C2-A03D-CFB5958272F9

Q34366802-0A3763F9-9C84-4AC9-9562-6DA2C755D943

Q34366802-114A5F4C-BEEA-4078-9D40-3FBC8E80D2EC

Q34366802-137ED335-59A5-49D5-B4E9-C191CBA937E1

Q34366802-16DB3C38-77D1-4EA7-B3AE-24CAACAFF7DE

Q34366802-16FDDC31-B5E3-40FE-BEB0-48399B467983

Q34366802-1B14E84D-86E1-45F4-8B73-234BB2EC4104

P304

Q34366802-D1CD2E23-5EDB-4C81-B37E-1A346D3426A7

P31

Q34366802-E8CFE658-66A4-4353-83DB-940E0BDDB214

P356

Q34366802-D3B62181-C29F-4804-95F5-B9026962FE03

P407

Q34366802-33FF94CD-4284-4C22-8CE9-32D5809D5BE8

P433

Q34366802-31E765C4-1DD1-418F-B450-CC632FD9CD45

P478

Q34366802-037114E6-7C15-4AB5-B731-05B5DC10332C

P577

Q34366802-9226A432-D4BF-4C31-9021-179717C8B083

P5875

Q34366802-26FE51C6-1119-4F99-8D71-A8FD9AC51E29

P698

Q34366802-50619170-E0A7-4146-938D-4AAF65C3032C

P921

Q34366802-170C086B-45E7-462C-9428-9AE247D5DF38

P356

14656566.2013.818978

P1433

Expert Opinion on Pharmacotherapy

P1476

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

@en

P2093

Henri-Jean Aubin

http://www.w3.org/2001/XMLSchema#string

Jacques Le Houezec

http://www.w3.org/2001/XMLSchema#string

P2860

Suicidal behavior and depression in smoking cessation treatments

The global research neglect of unassisted smoking cessation: causes and consequences

Mortality in relation to smoking: 50 years' observations on male British doctors

Nicotine addiction

Electronic nicotine delivery systems: a research agenda

Topiramate in the treatment of substance-related disorders: a critical review of the literature

Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis

Placebo-controlled trial of cytisine for smoking cessation

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers

P304

1959-1967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2013.818978

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256118596

http://www.w3.org/2001/XMLSchema#string

P698

23978314

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy